TY - JOUR
T1 - Respiratory and psychophysical sequelae among patients with covid-19 four months after hospital discharge
AU - Bellan, Mattia
AU - Soddu, Daniele
AU - Balbo, Piero Emilio
AU - Baricich, Alessio
AU - Zeppegno, Patrizia
AU - Avanzi, Gian Carlo
AU - Baldon, Giulia
AU - Bartolomei, Giuseppe
AU - Battaglia, Marco
AU - Battistini, Sofia
AU - Binda, Valeria
AU - Borg, Margherita
AU - Cantaluppi, Vincenzo
AU - Castello, Luigi Mario
AU - Clivati, Elisa
AU - Cisari, Carlo
AU - Costanzo, Martina
AU - Croce, Alessandro
AU - Cuneo, Daria
AU - De Benedittis, Carla
AU - De Vecchi, Simona
AU - Feggi, Alessandro
AU - Gai, Martina
AU - Gambaro, Eleonora
AU - Gattoni, Eleonora
AU - Gramaglia, Carla
AU - Grisafi, Leonardo
AU - Guerriero, Chiara
AU - Hayden, Eyal
AU - Jona, Amalia
AU - Invernizzi, Marco
AU - Lorenzini, Luca
AU - Loreti, Lucia
AU - Martelli, Maria
AU - Marzullo, Paolo
AU - Matino, Erica
AU - Panero, Antonio
AU - Parachini, Elena
AU - Patrucco, Filippo
AU - Patti, Giuseppe
AU - Pirovano, Alice
AU - Prosperini, Pierluigi
AU - Quaglino, Riccardo
AU - Rigamonti, Cristina
AU - Sainaghi, Pier Paolo
AU - Vecchi, Camilla
AU - Zecca, Erika
AU - Pirisi, Mario
N1 - Publisher Copyright:
© 2021 American Medical Association. All rights reserved.
PY - 2021/1/27
Y1 - 2021/1/27
N2 - Importance: Although plenty of data exist regarding clinical manifestations, course, case fatality rate, and risk factors associated with mortality in severe coronavirus disease 2019 (COVID-19), long-Term respiratory and functional sequelae in survivors of COVID-19 are unknown. Objective: To evaluate the prevalence of lung function anomalies, exercise function impairment, and psychological sequelae among patients hospitalized for COVID-19, 4 months after discharge. Design, Setting, and Participants: This prospective cohort study at an academic hospital in Northern Italy was conducted among a consecutive series of patients aged 18 years and older (or their caregivers) who had received a confirmed diagnosis of severe acute respiratory coronavirus 2 (SARS-CoV-2) infection severe enough to require hospital admission from March 1 to June 29, 2020. SARS-CoV-2 infection was confirmed via reverse transcription-polymerase chain reaction testing, bronchial swab, serological testing, or suggestive computed tomography results. Exposure: Severe COVID-19 requiring hospitalization. Main Outcomes and Measures: The primary outcome of the study was to describe the proportion of patients with a diffusing lung capacity for carbon monoxide (Dlco) less than 80% of expected value. Secondary outcomes included proportion of patients with severe lung function impairment (defined as Dlco<60% expected value); proportion of patients with posttraumatic stress symptoms (measured using the Impact of Event Scale-Revised total score); proportion of patients with functional impairment (assessed using the Short Physical Performance Battery [SPPB] score and 2-minute walking test); and identification of factors associated with Dlcoreduction and psychological or functional sequelae. Results: Among 767 patients hospitalized for severe COVID-19, 494 (64.4%) refused to participate, and 35 (4.6%) died during follow-up. A total of 238 patients (31.0%) (median [interquartile range] age, 61 [50-71] years; 142 [59.7%] men; median [interquartile range] comorbidities, 2 [1-3]) consented to participate to the study. Of these, 219 patients were able to complete both pulmonary function tests and Dlcomeasurement. Dlcowas reduced to less than 80% of the estimated value in 113 patients (51.6%) and less than 60% in 34 patients (15.5%). The SPPB score was suggested limited mobility (score <11) in 53 patients (22.3%). Patients with SPPB scores within reference range underwent a 2-minute walk test, which was outside reference ranges of expected performance for age and sex in 75 patients (40.5%); thus, a total of 128 patients (53.8%) had functional impairment. Posttraumatic stress symptoms were reported in a total of 41 patients (17.2%). Conclusions and Relevance: These findings suggest that at 4 months after discharge, respiratory, physical, and psychological sequelae were common among patients who had been hospitalized for COVID-19.
AB - Importance: Although plenty of data exist regarding clinical manifestations, course, case fatality rate, and risk factors associated with mortality in severe coronavirus disease 2019 (COVID-19), long-Term respiratory and functional sequelae in survivors of COVID-19 are unknown. Objective: To evaluate the prevalence of lung function anomalies, exercise function impairment, and psychological sequelae among patients hospitalized for COVID-19, 4 months after discharge. Design, Setting, and Participants: This prospective cohort study at an academic hospital in Northern Italy was conducted among a consecutive series of patients aged 18 years and older (or their caregivers) who had received a confirmed diagnosis of severe acute respiratory coronavirus 2 (SARS-CoV-2) infection severe enough to require hospital admission from March 1 to June 29, 2020. SARS-CoV-2 infection was confirmed via reverse transcription-polymerase chain reaction testing, bronchial swab, serological testing, or suggestive computed tomography results. Exposure: Severe COVID-19 requiring hospitalization. Main Outcomes and Measures: The primary outcome of the study was to describe the proportion of patients with a diffusing lung capacity for carbon monoxide (Dlco) less than 80% of expected value. Secondary outcomes included proportion of patients with severe lung function impairment (defined as Dlco<60% expected value); proportion of patients with posttraumatic stress symptoms (measured using the Impact of Event Scale-Revised total score); proportion of patients with functional impairment (assessed using the Short Physical Performance Battery [SPPB] score and 2-minute walking test); and identification of factors associated with Dlcoreduction and psychological or functional sequelae. Results: Among 767 patients hospitalized for severe COVID-19, 494 (64.4%) refused to participate, and 35 (4.6%) died during follow-up. A total of 238 patients (31.0%) (median [interquartile range] age, 61 [50-71] years; 142 [59.7%] men; median [interquartile range] comorbidities, 2 [1-3]) consented to participate to the study. Of these, 219 patients were able to complete both pulmonary function tests and Dlcomeasurement. Dlcowas reduced to less than 80% of the estimated value in 113 patients (51.6%) and less than 60% in 34 patients (15.5%). The SPPB score was suggested limited mobility (score <11) in 53 patients (22.3%). Patients with SPPB scores within reference range underwent a 2-minute walk test, which was outside reference ranges of expected performance for age and sex in 75 patients (40.5%); thus, a total of 128 patients (53.8%) had functional impairment. Posttraumatic stress symptoms were reported in a total of 41 patients (17.2%). Conclusions and Relevance: These findings suggest that at 4 months after discharge, respiratory, physical, and psychological sequelae were common among patients who had been hospitalized for COVID-19.
UR - https://www.scopus.com/pages/publications/85100594100
U2 - 10.1001/jamanetworkopen.2020.36142
DO - 10.1001/jamanetworkopen.2020.36142
M3 - Article
SN - 2574-3805
VL - 4
JO - JAMA network open
JF - JAMA network open
IS - 1
M1 - 36142
ER -